Navigation Links
Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
Date:11/1/2007

LONDON, Nov. 1 /PRNewswire/ -- Chiltern, a leading global clinical research organization, is pleased to announce that Diana Hatsis, R.N., B.S.N., C.O.T. will lecture at the JCAHPO annual continuing education program. Diana who designed an ophthalmic surgical instrument, the Hatsis LASIK Irrigation Cannula, worked in ophthalmic practice for several years prior to joining Chiltern as a Clinical Research Associate (CRA). The meeting will take place in New Orleans, Louisiana from November 9 - 13, 2007. The JCAHPO meetings will be located at the Hilton Riverside. Diana will be the lead instructor on three lectures, and co-instructing one of them with her brother, Dr. Alexander Hatsis, M.D., F.A.C.S. Dr. Hatsis was the first surgeon to perform refractive surgery with the Excimer laser on Long Island in 1995.

Monday, Nov. 12 from 11:30 am to 12:25 pm - Session 07M04

Wearing Many Hats: Managing Clinical Trials in an Ophthalmic Private

Practice

Tuesday, Nov, 13 from 10:20 am to 11:15 am - Session 04TU3

LASIK Complications (Lead Instructor: A. Hatsis, MD)

Tuesday, Nov, 13 from 11:30 am to 12:25 pm - Session 04TU4

Sands of the Sahara: A Refractive Emergency (co-instructor A. Hatsis, MD)

Tuesday, Nov, 13 from 1:50 pm to 2:45 pm - Session 07M06

Basic Surgical Assisting

"This will be my eighth year presenting at JCAHPO during AAO's annual meeting, it is always a great honor to be invited and a pleasure to teach and provide continuing education for health professionals in the field of ophthalmology," said Diana Hatsis. "My background in ophthalmology, eye surgeries, working in a private practice and now clinical research allows me to deliver courses with an insight in various aspects of the profession," Diana added.

"One of Chiltern's therapeutic expertise is ophthalmology and we have completed numerous trials, in various indications, in this area. Diana's expertise in the field of ophthalmology is well established and her passion about sharing her knowledge with others is reflected in the number of speaking engagements she has given over the years," said Kathy Zimmermann, Chiltern's Executive Director, Clinical Monitoring, Americas.

About Chiltern:

Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1100 people with 20 offices across the United States, United Kingdom, Germany, France, Italy, Spain, Poland, Czech Republic, Ukraine, India and South Africa. Chiltern provides services including Phase I and laboratory support, Global Clinical Development, Staff Resourcing, Biometrics, Regulatory and Medical Affairs.

For more information contact:

Catherine Lemercier

Chiltern International, Inc.

2111 Palomar Airport Road

Suite 200

Carlsbad

CA 92011

Tel: 1 (760) 707 5025

Fax: 1 (760) 707 5022

Email: Catherine.Lemercier@chiltern.com

Chiltern: Understanding


'/>"/>
SOURCE Chiltern International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bill to Ban Abortion In Indiana Introduced
2. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
3. Over 300 Ill After Eating at Olive Garden, Indianapolis
4. Many Indiana Citizens Do Not Possess Health Insurance Coverage
5. Diana Could Have Been Saved Had She Been Rushed to Hospital
6. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
7. Researchers Present Ways To Reduce The Risk Of Dementia
8. Researchers Present Data Regarding The Efficiency Of Herbs
9. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
10. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
11. Drug Reactions First Present Themselves In The Mouth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... ... An inventor, from Talladega, Ala., thought there needed to be a more ... , The SLING-VEST provides an effective way to support and align the arm or ... result, it helps to reduce discomfort and shifting. The invention features an effective design ...
(Date:12/6/2016)... ... ... Mount Sinai Health System today announced the creation of the Medical Modeling ... order 3D models for their cases. Virtual reality, simulation, and 3D printing services ... resource will be the first of its kind catering to the unique patient-specific modeling ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" or ... today that it entered into collaboration with Takeda ... the treatment of NASH and other gastrointestinal (GI) ... LUNAR™ and UNA Oligomer chemistry. The financial terms ... commitment to and expertise in GI disorders, we ...
(Date:12/6/2016)... 6, 2016 A new study released today ... 340B) projects the 340B Drug Pricing Program will continue to ... it is expected to exceed $23 billion in total purchases ... purchases surpass current Medicare Part B drug reimbursement purchases over ... – based on analysis of data on total drug purchases ...
Breaking Medicine Technology: